The spectrum of optic neuromyelitis (ONM) ranges from monophasic or recurrent idiopathic forms of the disease, to ONM associated with autoimmune disorders. A distinct form of the disease, called recurrent ONM with endocrinopathies, characterized by spinal cord involvement (cavitations with syringomyeloid sensory disturbance), rapid evolution to blindness and paraplegia, characteristic cerebrospinal fluid (CSF) findings, and association with hypothalamus Á pituitary dysfunction, has recently been described. The first case of ONM with endocrinopathies in a female Caucasian from Europe is presented, supporting the existence of this syndrome as a separate entity. Multiple Sclerosis 2006; 12: 670 Á 673. www.sagepub.co.uk
Introduction
A combination of optic neuritis (ON) and acute myelitis without involvement of the brain is usually considered to represent optic neuromyelitis (ONM), a disease that usually results in paraplegia and blindness. The diagnostic criteria for ONM distinguish the monophasic and recurrent forms of the disease [1] . In 1997, a distinct syndrome with clinical presentation of ON and acute myelitis, called recurrent optic neuromyelitis (RONM) with endocrinopathies, was first described in eight patients from French Antilles, and subsequently, in six patients from Brazil and one from China [2 Á 4] . We describe the first European case of the syndrome in a Caucasian female unrelated to the patients described to date.
Case report
In December 2002, a 44-year-old Caucasian female with a history of hypothyroidism and transitory thrombocytopenia during pregnancy developed ON on the right eye, with good recovery after retrobulbar corticosteroid therapy. In January 2004, she was hospitalized for paraplegia, sensory loss at the eighth thoracic level, and urinary and fecal incontinence. Cerebrospinal fluid (CSF) examination revealed pleocytosis of 245/3 (180 small lymphocytes, 32 neutrophils), with a protein level of 53 mg/100 mL. Oligoclonal IgG bands (OCB) were present in both CSF and serum. Viral, HIV, Borrelia burgdorferi , fungal and syphilis CSF serology and CSF bacterial cultures were negative, as were immunologic tests including anti-cardiolipin antibodies, lupus anti-coagulant, anti-nuclear antibodies and anti-dsDNA antibodies. Magnetic resonance imaging (MRI) was not performed on that occasion. Corticosteroid therapy (a five-day course of 1000 mg methylprednisolone, followed by dose tapering) resulted in only slight deficit improvement. Concurrently with this bout of the disease, but before corticosteroid treatment was started, the patient developed hyperphagia with weight gain (15 kg gain), and diabetes mellitus. At this point, thyroid hormones were within normal limits, and anti-thyroid peroxidase antibody was negative. Nine months later, she developed ON of the left eye, this time with only partial recovery. In December 2004, the patient developed an episode of acute, partial myelitis with left hemiparesis and ipsilateral temperature and pain loss in the segmental distribution of the trigeminal nerve, with contralateral temperature and pain loss on the body. Neurological examination revealed triplegia in extension, with hyperactivity of extensor reflexes and tonic extensor spasms of the left arm and lower limbs, with the legs in adduction and slight internal rotation. CSF revealed pleocytosis of 73/3 (38 small lymphocytes, 20 neutrophils and six eosinophils), protein 72 mg/100 mL, and IgG index of 9.8 )/10 3 . OCB were identical in serum and CSF, indicating that there was no intrathecal synthesis. CSF protein electrophoresis and immunoelectrophoresis were normal. Viral, HIV, B. burgdorferi , fungal and syphilis CSF serology were negative again. At this point, immunologic testing revealed an elevated level of anti-cardiolipin IgG antibodies (105 U/mL, normal valueB/10), again with negative lupus anti-coagulant, anti-nuclear antibodies and anti-dsDNA antibodies. However, two months later, a repeated measurement of anti-cardiolipin antibodies was negative. Electromyoneurography was normal, and visual evoked potentials revealed wave P100 of borderline latencies with low amplitudes. On spinal cord MRI, T1-and T2-weighted images ( Figure 1A ) showed a cavitation extending over the first six cervical vertebrae and a high signal intensity over the third and fourth thoracic vertebrae on T2-weighted images. On transverse images, an area of high signal intensity was present in the left lateral and dorsal columns of the cervical spine, indicating involvement of left tractus spinalis nervi trigemini and lateral spinotalamic tract ( Figure 1B) . A brain MRI was normal. Upon treatment with corticosteroids (a five-day course of 1000 mg methylprednisolone, followed by dose tapering), followed by plasmapheresis, immunoglobulin (35 g/5 days) and cyclophosphamide (60 mg three times daily) therapy, the neurological status was maintained stationary.
Discussion
RONM with endocrinopathies has been described as unique to black Antillean and Afro-Brazilian women. In the literature, there are reports on only two Caucasians from Brazil with this syndrome associated with diabetes mellitus or amenorrhea [3] , which makes our patient the first case of RONM with endocrinopathies described outside Brazil.
Our patient, with two bouts of ON, one of acute transverse myelitis and of partial myelitis each, and the absence of MRI lesions in the cerebral white matter, met the diagnostic criteria for ONM [1] , yet distinguished from ONM by several features. The first and most striking was the association with endocrinopathies including hypothyroidism, hyperphagia with obesity, and diabetes mellitus. The obesity and diabetes mellitus developed before introducing corticosteroid treatment, and these symptoms are very likely to be hypothalamic in origin. However, it is not possible to exclude the causal relationship between these two diseases, as type II diabetes can be a consequence of obesity. In addition, although anti-thyroid peroxidase antibodies were negative, hypothyroidism was diagnosed 15 years before the development of the first neurological symptoms, therefore it is not entirely possible to exclude an autoimmune origin of this endocrinopathy. The patient also suffered from amenorrhea, which corresponded with the second bout of the disease, but her age and negative prolactin levels made this symptom questionable. The spectrum of endocrinopathies in RONM patients ( Table 1 ) seems to be related to hypothalamus Á pituitary dysfunction, as gadolinium enhancement was observed in the pituitary of some patients from Martinique. Additionally, involvement of hypothalamic structures has recently been described in two patients with ONM, one of which has Haitian heritage [5] . These authors suggested that involvement of the hypothalamus should be included in the diagnostic criteria for ONM. However, we feel that hypothalamic involvement should be used as one of the markers (along with clinical picture, endocrinopathies and CSF findings) which distinguish RONM with endocrinopathies from classic ONM. It has also been shown that patients with a so-called Asian type of MS (which, in fact, represents RONM) may have elevated prolactin levels, which again implicates the involvement of hypothalamus Á pituitary level [6] . Although hyperphagia with obesity and amenorrhea in our patient were also suggestive of a disorder at the hypothalamus Á pituitary level, a brain MRI was normal.
CSF findings in patients with RONM are either normal or show pleocytosis with elevated protein level and negative OCB. In our patient, a character-istic finding was the presence of up to 41% of neutrophils in the CSF (negative CSF bacterial cultures on three occasions), clearly differentiating this syndrome from MS. CSF neutrophils have been reported in 60% of patients with recurrent ONM [1] , although it does not appear to hold for all recurrent ONM series [7] . Also, our patient showed the so-called mirror pattern, ie, identical OCB in both serum and CSF, which did not indicate intrathecal synthesis.
In patients presenting with symptoms of either ON or transverse myelitis, immunologic testing is of paramount importance, since the association with some connective tissue diseases implies a different mode of treatment. ONM in the presence of anti-cardiolipin antibodies is an indication for anti-coagulation therapy, although some authors suggest these antibodies to merely reflect polyclonal B-cell activation that is not organ specific [8] . Nevertheless, our patient did not meet the diagnostic criteria for anti-phospholipid syndrome [9] , anti-cardiolipin antibodies were positive on only one occasion, and other characteristic antibodies for systemic lupus erythematosus and other connective tissue disorders and vasculitis (anti-nuclear antibodies, anti-dsDNA antibodies and lupus anticoagulant) were repeatedly negative.
In conclusion, the patient presented had several characteristics of RONM with endocrinopathies: only the optic nerves and spinal cord were affected; there were no lesions in other parts of the central or peripheral nervous system; the clinical picture showed rapid evolution to triplegia and syringomyeloid sensory dissociation; endocrine disturbances including hypothyroidism, diabetes mellitus, hyperphagia with obesity, and amenorrhea; and MRI evidence of cavitations and demyelination of the cervical and thoracic spinal cord, 
